Reactions Weekly

, Volume 1695, Issue 1, pp 41–41 | Cite as


Development of resistance in the lung adenocarcinoma: case report
Case report


  1. Gu FF, et al. Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy. Journal of Hematology and Oncology 9: 66, No. 1, 5 Aug 2016. Available from: URL: - ChinaCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations